Wells Fargo & Company Forecasts Strong Price Appreciation for Sabra Healthcare REIT (NASDAQ:SBRA) Stock

Key Points

• Wells Fargo & Company has raised its target price for Sabra Healthcare REIT from $20.00 to $21.00, indicating a potential upside of 9.09% from the previous close.
• Several analysts have recently upgraded their ratings on SBRA, with JMP Securities setting a price target of $22.00, suggesting strong investment interest.
• Sabra Healthcare REIT reported $0.38 earnings per share for the last quarter, exceeding expectations and showing a year-over-year revenue increase of 7.4%.

Sabra Healthcare REIT (NASDAQ:SBRA - Free Report) had its price objective raised by Wells Fargo & Company from $20.00 to $21.00 in a report published on Wednesday,Benzinga reports. They currently have an overweight rating on the real estate investment trust's stock.

SBRA has been the subject of several other reports. BMO Capital Markets boosted their target price on Sabra Healthcare REIT from $19.00 to $22.00 and gave the stock a "market perform" rating in a report on Monday, August 25th. JMP Securities upped their price target on Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a "market outperform" rating in a report on Wednesday, August 6th. Finally, Scotiabank upped their price target on Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a "sector perform" rating in a report on Monday, June 23rd. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and four have issued a Hold rating to the company's stock. According to MarketBeat, Sabra Healthcare REIT currently has a consensus rating of "Moderate Buy" and an average target price of $20.43.

Sabra Healthcare REIT Stock Performance

SBRA traded down $0.20 on Wednesday, hitting $19.11. The company had a trading volume of 2,586,825 shares, compared to its average volume of 2,738,903. The company's fifty day moving average price is $18.56 and its 200 day moving average price is $17.80. Sabra Healthcare REIT has a 1-year low of $15.60 and a 1-year high of $20.03. The company has a debt-to-equity ratio of 0.91, a current ratio of 4.80 and a quick ratio of 4.80. The stock has a market cap of $4.58 billion, a price-to-earnings ratio of 25.15, a price-to-earnings-growth ratio of 1.52 and a beta of 0.88.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last posted its earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.02. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%.The firm had revenue of $189.15 million during the quarter, compared to analyst estimates of $185.64 million. During the same period in the previous year, the company earned $0.36 EPS. The company's revenue for the quarter was up 7.4% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. Equities analysts predict that Sabra Healthcare REIT will post 1.45 earnings per share for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, August 29th. Investors of record on Friday, August 15th were paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.3%. The ex-dividend date was Friday, August 15th. Sabra Healthcare REIT's dividend payout ratio is presently 157.89%.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of SBRA. Nuveen LLC acquired a new position in shares of Sabra Healthcare REIT in the first quarter valued at $61,791,000. Engineers Gate Manager LP raised its stake in shares of Sabra Healthcare REIT by 3,190.3% in the second quarter. Engineers Gate Manager LP now owns 3,179,303 shares of the real estate investment trust's stock valued at $58,626,000 after purchasing an additional 3,082,677 shares in the last quarter. Norges Bank acquired a new position in shares of Sabra Healthcare REIT in the second quarter valued at $54,385,000. Balyasny Asset Management L.P. acquired a new position in shares of Sabra Healthcare REIT in the second quarter valued at $49,955,000. Finally, Bank of Montreal Can raised its stake in shares of Sabra Healthcare REIT by 244.1% in the second quarter. Bank of Montreal Can now owns 2,575,969 shares of the real estate investment trust's stock valued at $47,501,000 after purchasing an additional 1,827,361 shares in the last quarter. 99.40% of the stock is currently owned by institutional investors and hedge funds.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.